V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006449 | 220016143 | 1.68 | 67.56 | Curative (C) | 2017-06-15 | 2017-06-18 | AML 19 TRIAL | N | N | 220030320 | AML19 TRIAL |
| 220006450 | 220002486 | 1.83 | 57.6 | Curative (C) | 2015-09-10 | 2015-09-10 | AML 19 TRIAL | 01 | N | 220030327 | AML19 TRIAL |
| 220006451 | 220002486 | 1.61 | 56.6 | Curative (C) | 2014-09-04 | 2014-09-05 | AML 19 TRIAL | null | null | 220030327 | AML19 TRIAL |
| 220006452 | 220002486 | null | null | null | 2015-10-25 | 2015-10-25 | Nilotinib | N | N | 220030327 | NILOTINIB |
| 220006453 | 220002487 | 1.78 | 0 | Palliative (P) | 2015-04-25 | 2015-04-25 | Nilotinib | N | Y | 220030332 | NILOTINIB |
| 220006454 | 220002487 | 1.61 | 0 | Disease modification (D) | 2015-11-20 | 2015-11-20 | Nilotinib | 02 | N | 220030332 | NILOTINIB |
| 220006455 | 220002488 | 1.62 | 58.5 | Curative (C) | 2013-12-08 | 2013-12-12 | AML Interim Guidelines FLAG-Ida | null | N | 220030337 | FLAG + IDARUBICIN |
| 220006456 | 220002488 | 1.75 | 115.9 | Curative (C) | 2013-04-05 | 2013-04-12 | AML 19 TRIAL | Y | N | 220030337 | AML19 TRIAL |
| 220006457 | 220002488 | null | 90 | Disease modification (D) | 2017-01-25 | 2017-01-25 | Nilotinib | 02 | N | 220030337 | NILOTINIB |
| 220006458 | 220002488 | 1.6 | null | Adjuvant (A) | 2014-09-18 | 2014-09-18 | FLAG + Idarubicin | null | N | 220030337 | FLAG + IDARUBICIN |
| 220006459 | 220002488 | 1.75 | null | Curative (C) | 2013-07-12 | 2013-07-18 | AML 19 TRIAL | 01 | N | 220030337 | AML19 TRIAL |
| 220006460 | 220002488 | 1.68 | 68.4 | Curative (C) | 2014-07-15 | 2014-07-15 | AML 19 TRIAL | N | N | 220030337 | AML19 TRIAL |
| 220006461 | 220002488 | null | 76.4 | Curative (C) | 2016-11-18 | 2016-11-21 | AML 19 TRIAL | Y | N | 220030337 | AML19 TRIAL |
| 220006462 | 220002489 | 1.62 | null | Curative (C) | 2014-11-14 | 2014-11-14 | FLAG + Idarubicin | 2 | N | 220030352 | FLAG + IDARUBICIN |
| 220006463 | 220002489 | 1.76 | 71.5 | Curative (C) | 2013-07-04 | 2013-07-04 | FLAG + Idarubicin | 2 | N | 220030352 | FLAG + IDARUBICIN |
| 220006464 | 220002490 | 1.5 | 55.7 | Curative (C) | 2016-10-09 | 2016-10-09 | AML 19 TRIAL | Y | N | 220030354 | AML19 TRIAL |
| 220006465 | 220002491 | null | 35.3 | Curative (C) | 2013-11-18 | 2013-11-19 | AML MyeChild | N | N | 220030357 | NOT MATCHED |
| 220006466 | 220002491 | null | 76 | Curative (C) | 2013-02-07 | 2013-02-08 | AML 19 TRIAL | 01 | null | 220030357 | AML19 TRIAL |
| 220006467 | 220002491 | 1.86 | 74.2 | Curative (C) | 2014-10-08 | 2014-10-08 | AML 19 TRIAL | 1 | N | 220030357 | AML19 TRIAL |
| 220006468 | 220002491 | 1.75 | 82.1 | Curative (C) | 2017-11-05 | 2017-11-07 | Nilotinib | 02 | N | 220030357 | NILOTINIB |
| 220006469 | 220002491 | 0 | 66.2 | Disease modification (D) | 2017-01-25 | 2017-01-28 | Nilotinib | 02 | N | 220030357 | NILOTINIB |
| 220006470 | 220002492 | 1.65 | 76.7 | Curative (C) | 2015-01-03 | 2015-01-03 | AML 19 TRIAL | Y | N | 220030366 | AML19 TRIAL |
| 220006471 | 220002492 | 1.84 | 65.3 | Curative (C) | 2014-02-18 | 2014-02-18 | AML 19 TRIAL | Y | N | 220030366 | AML19 TRIAL |
| 220006472 | 220002492 | 0 | 0 | Disease modification (D) | 2015-05-07 | 2015-05-07 | Nilotinib | N | N | 220030366 | NILOTINIB |
| 220006473 | 220002493 | 1.82 | 77 | Curative (C) | 2013-03-01 | 2013-03-01 | AML 19 TRIAL | Y | N | 220030369 | AML19 TRIAL |
| 220006474 | 220002493 | 1.53 | null | Curative (C) | 2014-05-24 | 2014-05-27 | FLAG + Idarubicin | N | N | 220030369 | FLAG + IDARUBICIN |
| 220006475 | 220002494 | 1.74 | null | Curative (C) | 2014-04-20 | 2014-04-20 | AML 19 TRIAL | Y | N | 220030379 | AML19 TRIAL |
| 220006476 | 220011427 | null | null | null | null | 2014-10-16 | Nilotinib | 02 | N | 220030383 | NILOTINIB |
| 220006477 | 220002495 | 1.85 | 74 | Curative (C) | 2014-12-10 | 2014-12-14 | AML 19 TRIAL | N | N | 220030389 | AML19 TRIAL |
| 220006478 | 220002496 | 0 | 64 | Disease modification (D) | null | 2013-05-24 | Nilotinib | N | Y | 220030391 | NILOTINIB |
| 220006479 | 220002496 | null | null | Curative (C) | 2013-01-18 | 2014-01-21 | Nilotinib | 02 | N | 220030391 | NILOTINIB |
| 220006480 | 220002496 | 1.58 | 97.2 | Curative (C) | 2014-05-17 | 2014-05-17 | AML 19 TRIAL | Y | null | 220030391 | AML19 TRIAL |
| 220006481 | 220002496 | 1.71 | 58.3 | Curative (C) | 2014-02-21 | 2014-02-20 | AML 19 TRIAL | Y | N | 220030391 | AML19 TRIAL |
| 220006482 | 220002496 | 0 | 0 | Palliative (P) | 2013-12-28 | 2013-12-28 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220030391 | NOT MATCHED |
| 220006483 | 220002497 | 1.85 | 61.9 | Curative (C) | 2017-01-08 | 2017-01-08 | AML Interim Guidelines FLAG-Ida | N | N | 220030400 | FLAG + IDARUBICIN |
| 220006484 | 220002497 | 1.61 | null | Curative (C) | 2015-09-23 | 2015-09-26 | AML 19 TRIAL | Y | N | 220030400 | AML19 TRIAL |
| 220006485 | 220002497 | null | null | Curative (C) | 2014-10-29 | 2014-10-29 | Nilotinib | N | N | 220030400 | NILOTINIB |
| 220006488 | 220002499 | 1.55 | 77 | Curative (C) | 2015-10-24 | 2015-10-25 | AML 19 TRIAL | Y | N | 220030413 | AML19 TRIAL |
| 220006489 | 220002499 | null | 83.7 | Curative (C) | 2013-08-21 | 2013-08-22 | AML 19 TRIAL | N | N | 220030413 | AML19 TRIAL |
| 220006490 | 220002500 | null | null | Curative (C) | 2017-06-07 | 2017-06-08 | null | N | N | 220030417 | NOT MATCHED |
| 220006491 | 220002500 | 0 | 15.8 | Curative (C) | 2011-08-29 | 2013-04-30 | CML Dasatinib | 02 | N | 220030417 | NOT MATCHED |
| 220006492 | 220002500 | 0 | 64 | Adjuvant (A) | 2016-09-12 | 2016-09-12 | Nilotinib | 02 | N | 220030417 | NILOTINIB |
| 220006493 | 220002501 | null | 12.8 | Curative (C) | 2013-08-22 | 2013-08-24 | AML Interim Guidelines | Y | N | 220030423 | NOT MATCHED |
| 220006494 | 220002501 | null | 86.5 | Curative (C) | 2013-04-13 | 2013-05-07 | Nilotinib | N | N | 220030423 | NILOTINIB |
| 220006495 | 220002502 | null | 80.4 | Palliative (P) | 2015-08-29 | 2015-08-29 | Nilotinib | 2 | N | 220030426 | NILOTINIB |
| 220006496 | 220002502 | null | 82 | Curative (C) | 2013-05-30 | 2013-12-11 | Nilotinib | 02 | N | 220030426 | NILOTINIB |
| 220006497 | 220002502 | 1.84 | 45.7 | Curative (C) | 2016-08-01 | 2016-08-02 | AML 19 TRIAL | Y | N | 220030426 | AML19 TRIAL |
| 220006498 | 220002503 | null | 0 | Palliative (P) | 2017-02-16 | 2017-02-19 | Nilotinib | 02 | N | 220030435 | NILOTINIB |
| 220006499 | 220002504 | 1.55 | 68.3 | Curative (C) | 2013-02-05 | 2013-02-09 | AML 19 TRIAL | 02 | N | 220030438 | AML19 TRIAL |
| 220006500 | 220011435 | 0 | 0 | Disease modification (D) | 2017-01-13 | 2017-01-27 | Nilotinib | N | N | 220030439 | NILOTINIB |